The major aim of all vaccination strategies is disease reduction goals by getting high levels of immunity in the targeted group of people via adequate vaccination coverage and vaccine effectiveness. The idea is to boost immune system of individuals to prevent the spread of the disease.
These are some different type of vaccination strategies given below:
Pulse vaccination strategy: The pulse vaccination strategy is the process used to eliminate an epidemic by repeatedly vaccinating a group of people at risk, over a defined age range, until the spread of the microbe has been come to an end. It is mostly used during the time of polio and measles epidemics to quickly end the spread and contain the outbreak.
Ring vaccination: The method of vaccination of all infected individuals in a prescribed area around an outbreak of an infectious disease. The Ring vaccination process helps to controls an outbreak by monitoring and vaccinating a ring of people around each infected individual. The idea is to boost immune system of individuals to prevent the spread of the disease.
Cocooning (immunization): Cocooning process also known as the Cocoon Strategy, is an immunization strategy to protect young child and other vulnerable individuals from the infectious diseases by vaccinating those who are in close contact with them. If the groups of people most likely to transmit an infection are immune, their immunity creates a "cocoon" of protection around the newborn or the vulnerable persons.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Capillary electrophoresis for adjuvanted multivalent recombinant vaccine purity determination
Ashley Prout, Merck, United States